Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction

被引:10
|
作者
Hama, Mamadou Kourna [1 ]
Khan, Dam [2 ]
Laouali, Boubou [1 ]
Okoi, Catherine [2 ]
Yam, Abdoulaye [3 ]
Haladou, Moussa [3 ]
Worwui, Archibald [2 ]
Ndow, Peter Sylvanus [2 ]
Obama, Ricardo Nse [3 ]
Mwenda, Jason M. [4 ]
Biey, Joseph [4 ]
Ntsama, Bernard [5 ]
Kwambana-Adams, Brenda A. [2 ]
Antonio, Martin [2 ,6 ]
Senghore, Madikay
Usuf, Effua
Uzochukwu, Egere
Zaman, Akram
Gehre, Florian
Tientcheu, Leopold
Mohammed, Nuredin Ibrahim
Dube, Felix
Ndow, Peter
Sambou, Suso
Jarju, Sheikh
Khan, Dam [2 ]
Chinelo, Ebruke
Bancroft, Rowan
机构
[1] Lab Hop Natl Niamey, Niamey, Niger
[2] London Sch Hyg & Trop Med, Med Res Council Unit Gambia, Collaborating Ctr New Vaccines Surveillance, WHO, London, England
[3] WHO Country Off, Niamey, Niger
[4] WHO Reg Off Africa, Brazzaville, Rep Congo
[5] WHO Intercountry Support Team West Africa, Ouagadougou, Burkina Faso
[6] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England
关键词
meningitis; Niger; cerebrospinal fluid; N; meningitidis; S; pneumoniae; HAEMOPHILUS-INFLUENZAE; ANTIMICROBIAL RESISTANCE; MENINGOCOCCAL SEROGROUP; PHYLOGENETIC ANALYSIS; DISEASE; EPIDEMIC; OUTBREAK; NIAMEY; ASSAY; TOOL;
D O I
10.1093/cid/ciz598
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Meningitis is endemic in Niger. Haemophilus influenzae type b (Hib) vaccine and the 13-valent pneumococcal conjugate vaccine (PCV13) were introduced in 2008 and 2014, respectively. Vaccination campaign against Neisseria meningitidis serogroup A was carried out in 2010-2011. We evaluated changes in pathogen distribution using data from hospital-based surveillance in Niger from 2010 through 2016. Methods. Cerebrospinal fluid (CSF) specimens from children <5 years old with suspected meningitis were tested to detect vaccine-preventable bacterial pathogens. Confirmatory identification and serotyping/grouping of Streptococcus pneumoniae, N. meningitidis, and H. influenzae were done. Antimicrobial susceptibility testing and whole genome sequencing were performed on S. pneumoniae isolates. Results. The surveillance included 2580 patients with suspected meningitis, of whom 80.8% (2085/2580) had CSF collected. Bacterial meningitis was confirmed in 273 patients: 48% (131/273) was N. meningitidis, 45% (123/273) S. pneumoniae, and 7% (19/273) H. influenzae. Streptococcus pneumoniae meningitis decreased from 34 in 2014, to 16 in 2016. PCV13 serotypes made up 88% (7/8) of S. pneumoniae meningitis prevaccination and 20% (5/20) postvaccination. Neisseria meningitidis serogroup C (NmC) was responsible for 59% (10/17) of serogrouped N. meningitidis meningitis. Hib caused 67% (2/3) of the H. influenzae meningitis isolates serotyped. Penicillin resistance was found in 16% (4/25) of S. pneumoniae isolates. Sequence type 217 was the most common lineage among S. pneumoniae isolates. Conclusions. Neisseria meningitidis and S. pneumoniae remain important causes of meningitis in children in Niger. The decline in the numbers of S. pneumoniae meningitis post-PCV13 is encouraging and should continue to be monitored. NmC is the predominant serogroup causing N. meningitidis meningitis.
引用
收藏
页码:S133 / S139
页数:7
相关论文
共 50 条
  • [1] Trends in pneumococcal meningitis hospitalizations following the introduction of the 13-valent pneumococcal conjugate vaccine in the United States
    Jacobs, David M.
    Yung, Francine
    Hart, Emily
    Nguyen, Melanie N. H.
    Shaver, Amy
    VACCINE, 2017, 35 (45) : 6160 - 6165
  • [2] Hospital-based Surveillance for Pediatric Bacterial Meningitis in the Era of the 13-Valent Pneumococcal Conjugate Vaccine in Ghana
    Renner, Lorna Awo
    Usuf, Effua
    Mohammed, Nuredin Ibrahim
    Ansong, Daniel
    Dankwah, Thomas
    Kusah, Jonas Tettey
    Owusu, Sandra Kwarteng
    Awunyo, Marah
    Arhin, Bernard
    Addo, Yvonne
    Asamoah, John
    Biey, Joseph Nsiari-Muzeyi
    Ndow, Peter Slyvanus
    Worwui, Archibald
    Senghore, Madikay
    Ntsama, Bernard
    Mwenda, Jason M.
    Diamenu, Stanley K.
    Adams, Brenda Kwanbana
    Antonio, Martin
    CLINICAL INFECTIOUS DISEASES, 2019, 69 : S89 - S96
  • [3] Meningitis Due to Streptococcus pneumoniae Serotype 24A in a Child Vaccinated with 13-valent Pneumococcal Conjugate Vaccine
    Akturk, Hacer
    Akoglu, Handan Ayhan
    Oksuz, Lutfiye
    Gurler, Nezahat
    Yalcin, Emek Uyur
    Hacifazlioglu, Nilufer Eldes
    Kulcu, Nihan Uygur
    Yildiz, Feyza Mediha
    JOURNAL OF PEDIATRIC INFECTION, 2019, 13 (01): : E39 - E41
  • [4] Clinical and Bacteriological Analysis of Pediatric Pneumococcal Meningitis after 13-Valent Pneumococcal Conjugate Vaccine Introduction in Japan
    Kurihara, Erika
    Takeshita, Kenichi
    Tanaka, Saori
    Takeuchi, Noriko
    Ohkusu, Misako
    Hishiki, Haruka
    Ishiwada, Naruhiko
    MICROBIOLOGY SPECTRUM, 2022, 10 (02):
  • [5] Impact of the 13-valent pneumococcal conjugate vaccine on Streptococcus pneumoniae multiple serotype carriage
    Valente, Carina
    Hinds, Jason
    Gould, Katherine A.
    Pinto, Francisco R.
    de Lencastre, Herminia
    Sa-Leao, Raquel
    VACCINE, 2016, 34 (34) : 4072 - 4078
  • [6] Trends of Pneumococcal Meningitis in Children After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in France
    Levy, Corinne
    Varon, Emmanuelle
    Picard, Capucine
    Bechet, Stephane
    Martinot, Alain
    Bonacorsi, Stephane
    Cohen, Robert
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (12) : 1216 - 1221
  • [7] Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010
    Demczuk, Walter H. B.
    Martin, Irene
    Griffith, Averil
    Lefebvre, Brigitte
    McGeer, Allison
    Shane, Amanda
    Zhanel, George G.
    Tyrrell, Gregory J.
    Gilmour, Matthew W.
    CANADIAN JOURNAL OF MICROBIOLOGY, 2012, 58 (08) : 1008 - 1017
  • [8] Recognition and Outcomes of Pneumococcal Meningitis in 2 Tertiary Pediatric Hospitals Since the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine
    Stevens, James Patrick
    Lively, Austin
    Jerris, Robert
    Yildirim, Inci
    Lantis, Patricia
    PEDIATRIC EMERGENCY CARE, 2022, 38 (01) : E354 - E359
  • [9] Pneumococcal meningitis in adults in 2014-2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan
    Chang, Bin
    Tamura, Kosuke
    Fujikura, Hiroyuki
    Watanabe, Hiroshi
    Tanabe, Yoshinari
    Kuronuma, Koji
    Fujita, Jiro
    Oshima, Kengo
    Maruyama, Takaya
    Abe, Shuichi
    Kasahara, Kei
    Nishi, Junichiro
    Kubota, Tetsuya
    Kinjo, Yuki
    Serizawa, Yusuke
    Shimbashi, Reiko
    Fukusumi, Munehisa
    Shimada, Tomoe
    Sunagawa, Tomimasa
    Suzuki, Motoi
    Oishi, Kazunori
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [10] Serotype Distribution of Clinical Streptococcus pneumoniae Isolates before the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Cambodia
    Inghammar, Malin
    By, Youlet
    Farris, Christina
    Phe, Thong
    Borand, Laurence
    Kerleguer, Alexandra
    Goyet, Sophie
    Saphonn, Vonthanak
    Phoeung, Chanleakhena
    Vong, Sirenda
    Rammaert, Blandine
    Mayaud, Charles
    Guillard, Bertrand
    Yasuda, Chadwick
    Kasper, Matthew R.
    Ford, Gavin
    Newell, Steven W.
    An, Ung Sam
    Sokhal, Buth
    Touch, Sok
    Turner, Paul
    Jacobs, Jan
    Messaoudi, Melina
    Komurian-Pradel, Florence
    Tarantola, Arnaud
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 98 (03) : 791 - 796